Glaxosmithkline Share Price | |
---|---|
Price | 1,660.80 |
Bid | 1,610.00 |
Ask | 1,715.00 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 1,660.80 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 4.06b |
Market Capitalisation | £67.40b |
Market Size | 1,500 |
52 Week High | 1,719.80 |
52 Week High Date | 07-Mar-2024 |
52 Week Low | 1,302.60 |
52 Week Low Date | 11-Jul-2023 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | 13.65789 |
Earnings | 121.60 |
Dividend | 55.50 |
Yield | 3.342% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
18-Mar-24 | 18:06:10 | 1,654.232 | 14,466 | Unknown* | 1,660.80 | 1,661.40 | 239.30k | O Ordinary Was reported as OTC |
18-Mar-24 | 18:05:34 | 1,659.323 | 14,852 | Unknown* | 1,660.80 | 1,661.40 | 246.44k | O Ordinary Was reported as OTC |
18-Mar-24 | 18:04:56 | 1,652.059 | 91,811 | Unknown* | 1,660.80 | 1,661.40 | 2m | O Ordinary Was reported as OTC |
18-Mar-24 | 18:03:25 | 1,651.91841 | 201 | Unknown* | 1,660.80 | 1,661.40 | 3,320 | O Ordinary Was reported as OTC |
18-Mar-24 | 17:59:24 | 1,647.235 | 3 | Unknown* | 1,660.80 | 1,661.40 | 49.42 | O Ordinary Was reported as OTC |
18-Mar-24 | 17:59:24 | 1,661.398 | 12,064 | Unknown* | 1,660.80 | 1,661.40 | 200.43k | O Ordinary Was reported as OTC |
18-Mar-24 | 17:59:24 | 1,653.819 | 3,695 | Unknown* | 1,660.80 | 1,661.40 | 61.11k | O Ordinary Was reported as OTC |
18-Mar-24 | 17:59:24 | 1,647.235 | 3 | Unknown* | 1,660.80 | 1,661.40 | 49.42 | O Ordinary Was reported as OTC |
18-Mar-24 | 17:59:24 | 1,660.664 | 1,832 | Unknown* | 1,660.80 | 1,661.40 | 30.42k | O Ordinary Was reported as OTC |
18-Mar-24 | 17:59:24 | 1,661.428 | 1,786 | Unknown* | 1,660.80 | 1,661.40 | 29.67k | O Ordinary Was reported as OTC |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
26-Feb-24 | 22-Feb-24 | Buy | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 21.08 | USD | 140 | 464,040 |
26-Feb-24 | 22-Feb-24 | Buy | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 22.00 | USD | 5,547 | 464,040 |
19-Feb-24 | 16-Feb-24 | Transfer From | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 0.00 | 297,429 | 349,880 | |
19-Feb-24 | 16-Feb-24 | Sell | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 1,657.97 | GBX | 139,792 | 349,880 |
15-Feb-24 | 12-Feb-24 | Transfer From | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 0.00 | 52,435 | 52,451 |
At GSK, we unite science, technology and talent to get ahead of disease together